It is recommended that women between 30 and 65 undergo co-testing with Human papillomavirus (HPV) and Pap smear testing every five years or Pap testing alone every three years.

Cervical dysplasia is the presence of abnormal cells in the cervix. Cases are classified as mild, moderate or severe depending on the extent of abnormal cell growth. Although the precise cause of ...

Historical Evolution of the Malawi National Cancer Registry: A Collaborative Effort to Develop and Sustain an Impactful Cancer Control Resource in a Low-Income Country Screening followed by treatment ...

Low-income American women and women in developing countries who are tested for cervical cancer could benefit from faster, more aggressive treatment, two studies suggest. Some of those women would be ...

Who knew that the key to preventing cervical cancer could be as simple as table vinegar? In a method developed by experts at Johns Hopkins medical school and recently endorsed by the World Health ...

A new study led by Columbia University Medical Center researchers demonstrates the safety and efficacy of two low-tech diagnostic tools to significantly reduce the prevalence of cervical cancer ...

Objective To compare the diagnostic accuracy of minipad collected menstrual blood versus clinician collected cervical samples to test for human papillomavirus (HPV) in the detection of cervical ...